P3 Health Partners Analyst Ratings
P3 Health Partners Analyst Ratings
While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a initiated with a price target of $0.00 to $5.00. The current price P3 Health Partners (PIII) is trading at is $1.98, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 152.53% | BTIG | → $5 | Initiates Coverage On | → Buy |
| 06/30/2023 | — | TD Cowen | Initiates Coverage On | → Market Perform | |
| 01/04/2022 | — | William Blair | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/01/2023 | 152.53% | BTIG | →$5 | 開始承保 | →購買 |
| 2023/06/30 | - | TD Cowen | 開始承保 | →市場表現 | |
| 01/04/2022 | - | 威廉·布萊爾 | 開始承保 | →跑贏大盤 |
What is the target price for P3 Health Partners (PIII)?
P3 Health Partners(PIII)的目標價格是多少？
The latest price target for P3 Health Partners (NASDAQ: PIII) was reported by BTIG on September 1, 2023. The analyst firm set a price target for $5.00 expecting PIII to rise to within 12 months (a possible 152.53% upside). 2 analyst firms have reported ratings in the last year.
BTIG於2023年9月1日報道了P3健康合作夥伴(納斯達克：PIII)的最新目標價。這家分析公司將目標價定為5美元，預計PIII將在12個月內上漲至(可能上漲152.53%)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for P3 Health Partners (PIII)?
P3 Health Partners(PIII)的最新分析師評級是多少？
The latest analyst rating for P3 Health Partners (NASDAQ: PIII) was provided by BTIG, and P3 Health Partners initiated their buy rating.
納斯達克對P3健康夥伴(BTIG：PIII)的最新分析師評級是由畢馬威提供的，P3健康夥伴發起了買入評級。
When is the next analyst rating going to be posted or updated for P3 Health Partners (PIII)?
P3 Health Partners(PIII)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P3 Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P3 Health Partners was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與P3 Health Partners的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。P3 Health Partners的上一次評級是在2023年9月1日提交的，因此您應該預計下一次評級將在2024年9月1日左右提供。
Is the Analyst Rating P3 Health Partners (PIII) correct?
分析師對P3 Health Partners(PIII)的評級正確嗎？
While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a initiated with a price target of $0.00 to $5.00. The current price P3 Health Partners (PIII) is trading at is $1.98, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的P3健康夥伴(PIII)評級是以0.00美元至5.00美元的目標價啟動的。P3 Health Partners(PIII)目前的交易價格為1.98美元，在分析師的預測範圍內。